(Q39583037)

English

Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.

scientific article published on March 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

title

Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

main subject

Adaptive radiation therapy

0 references

1 reference

3

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

author name string

Arunkumar Anandharaj

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

Senthilkumar Cinghu

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

publication date

1 March 2011

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

published in

Acta Biochimica et Biophysica Sinica

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

volume

43

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 January 2020

page(s)

292-300

1 reference

stated in

Europe PubMed Central

PubMed ID

21367753

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21367753%20AND%20SRC:MED&resulttype=core&format=json

(Q39583037)

Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)